Fasciola Hepatica IgG Test: A Diagnostic Tool for Detecting Fasciola Hepatica Parasite Infections

The Fasciola Hepatica IgG test, manufactured by Pishtaz Teb in Iran, is a highly effective diagnostic tool used to detect the presence of the Fasciola hepatica parasite in both livestock and humans. This trematode parasite primarily affects animals such as cattle and sheep but has increasingly been causing infections in humans since 1980.

With its prevalence in many regions worldwide, this parasite has led to epidemics being reported in various countries. The complications of fascioliasis, which is the disease caused by the Fasciola hepatica parasite, are mainly attributed to the migration of the parasite to the liver and biliary tract, resulting in significant damage to the liver hepatocytes.

In advanced stages of the disease, the presence of adult worms in the bile ducts can cause both mechanical and toxic damage. Furthermore, secondary bacterial infections can arise, leading to cirrhosis. Clinical symptoms of fascioliasis in humans include liver spasms, nausea, vomiting, abdominal pain, headache, fever, diarrhea, anemia, and eosinophilia.

Reliable and Timely Diagnosis with the ELISA Test

While the definitive diagnosis of fascioliasis involves identifying parasite eggs in feces or duodenal lavage, this confirmatory test has certain limitations, including a delay of 7-11 weeks from the onset of infection. False positive results may also occur if patients consume animal liver containing parasite eggs.

To overcome these challenges, the Fasciola Hepatica IgG test provides a more reliable and timely diagnosis. Manufactured by Pishtaz Teb in Iran, this diagnostic tool utilizes the Enzyme-Linked Immunosorbent Assay (ELISA) technique. It has a sensitivity of approximately 98% and can detect the infection as early as 2-4 weeks post-infection.

One significant advantage of the ELISA test is its minimal cross-reactivity with other parasites, such as Schistosoma. This ensures accurate detection of Fasciola hepatica infections without interference from unrelated parasitic infections.

Main Features:

Highly effective diagnostic tool for detecting Fasciola hepatica parasite infections
Manufactured by Pishtaz Teb in Iran
Suitable for both livestock and human testing
Prevalent in many regions worldwide with reported epidemics in various countries
Complications include liver damage, bile duct obstruction, and secondary bacterial infections leading to cirrhosis
Clinical symptoms may include liver spasms, nausea, vomiting, abdominal pain, headache, fever, diarrhea, anemia, and eosinophilia
Definitive diagnosis through identification of parasite eggs in feces or duodenal lavage
ELISA test offers reliable and timely diagnosis with a sensitivity of approximately 98%
Minimal cross-reactivity with other parasites, ensuring accurate results

With the Fasciola Hepatica IgG test, manufactured by Pishtaz Teb in Iran, healthcare professionals can confidently detect Fasciola hepatica infections and initiate appropriate treatment promptly.